• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of micro RNA in chemo- resistance of uterine serous carcinoma

Research Project

Project/Area Number 24592498
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Obstetrics and gynecology
Research InstitutionYamagata University (2014)
Tohoku University (2012-2013)

Principal Investigator

NAGASE Satoru  山形大学, 医学部, 教授 (00292326)

Co-Investigator(Kenkyū-buntansha) SUSUKI Fumihiko  東北大学, 医学(系)研究科(研究院), 助教 (20400343)
YOSHINAGA Kousuke  東北大学, 医学(系)研究科(研究院), 非常勤講師 (40343058)
TANNO Sumika  東北大学, 医学(系)研究科(研究院), 非常勤講師 (60509595)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Keywords子宮体癌 / 漿液性腺癌 / マイクロRNA / マイクロアレイ / 薬剤耐性
Outline of Final Research Achievements

To elucidate mechanisms of chemo-resistance for platinum and taxane from the aspect of microRNA (miRNA), we used USPC-1 and constructed its chemo-resistant variant PTX-R and CDDP-R. By microRNA microarray analysis, we focused on let-7c. We confirmed that the expression of let-7c was decreased significantly in both drug-resistant cells (P<0.05). Cell viability was decreased after let-7c mimic transfection to PTX-R followed by PTX treatment and similar transfection to CDDP-R followed by CDDP treatment. HMGA2 is known as the most famous target of let-7c and let-7c mimic transfection revealed decreased expression of HMGA2 (p<0.05). ABC transporters such as ABCB1, ABCC1, ABCC2, ABCG2, are the important molecules in the drug resistance, and the expression of ABCC1 was decreased significantly by let-7c inhibitor transfection to parental cells (p<0.05). These data shows that let-7c may involve in drug resistance of PTX and CDDP via HMGA2 or ABCC1 in USC.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (12 results)

All 2015 2014 2013 2012 Other

All Journal Article (5 results) (of which Peer Reviewed: 4 results,  Acknowledgement Compliant: 1 results) Presentation (7 results) (of which Invited: 1 results)

  • [Journal Article] Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.2015

    • Author(s)
      Mashiko S, Kitatani K, Toyoshima M, Ichimura A, Dan T, Usui T, Ishibashi M, Shigeta S, Nagase S, Miyata T, Yaegashi N
    • Journal Title

      Cancer Biology & Therapy

      Volume: 16 Issue: 2 Pages: 253-260

    • DOI

      10.1080/15384047.2014.1001271

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.2014

    • Author(s)
      Konno Y, Dong P, Xiong Y, Suzuki F, Lu J, Cai M, Watari H, Mitamura T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N.
    • Journal Title

      Oncotarget

      Volume: 5(5) Pages: 6049-6062

    • NAID

      120005690901

    • Related Report
      2014 Annual Research Report
  • [Journal Article] Molecular Pathogenesis of Uterine Serous Carcinoma2014

    • Author(s)
      Satoru Nagase ・ Fumihiko Suzuki ・ Hideki Tokunaga ・Masafumi Toyoshima ・ Hiroki Utsunomiya ・Hitoshi Niikura ・ Nobuo Yaegashi
    • Journal Title

      Curr Obstet Gynecol Rep

      Volume: 3 Issue: 1 Pages: 33-39

    • DOI

      10.1007/s13669-013-0069-0

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Decreased Expression of 14-3-3<i>σ</i> Is Predictive of Poor Prognosis for Patients with Human Uterine Papillary Serous Carcinoma2013

    • Author(s)
      1. Suzuki F, Nagase S, Suzuki K, Oba E, Hiroki E, Matsuda Y, Akahira J, Nishigori H, Sugiyama T, Otsuki T, Yoshinaga K, Takano T, Niikura H, Ito K, Sasano H, and Yaegashi N
    • Journal Title

      The Tohoku Journal of Experimental Medicine

      Volume: 231 Issue: 3 Pages: 193-199

    • DOI

      10.1620/tjem.231.193

    • NAID

      130004720755

    • ISSN
      0040-8727, 1349-3329
    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma2012

    • Author(s)
      Hiroki E, Akahira J, et al
    • Journal Title

      Int J Cancer

      Volume: (印刷中) Issue: 4 Pages: 395-404

    • DOI

      10.1002/ijc.27345

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] MiR-34b correlates tumor growth and invasion in uterine serous carcinoma.2015

    • Author(s)
      Fumihiko Suzuki, Satoru Nagase, Yoh Watanabe, Izumi Sato, Hiroki Utsunomiya, Michiko Kaiho, Hideki Tokunaga, Hitoshi Niikura, Tadao Takano, Hironobu Sasano and Nobuo Yaegashi
    • Organizer
      62nd Annual Meeting of the society for Reproductive Investigation
    • Place of Presentation
      Hilton San Francisco (San Francisco, USA)
    • Year and Date
      2015-03-25 – 2015-03-28
    • Related Report
      2014 Annual Research Report
  • [Presentation] 子宮体部漿液性腺癌細胞株においてlet-7cは多剤耐性取得機序に関与している2014

    • Author(s)
      佐藤いずみ、鈴木史彦、永瀬智、高野忠夫、新倉仁、伊藤潔、渡部洋、八重樫伸生
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      2014-09-25 – 2014-09-27
    • Related Report
      2014 Annual Research Report
  • [Presentation] 子宮体部漿液性腺癌におけるmiR-101の機能解析2014

    • Author(s)
      鈴木史彦、永瀬智、渡部洋、佐藤いずみ、宇都宮裕貴、新倉仁、笹野公伸、八重樫伸生
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      2014-09-25 – 2014-09-27
    • Related Report
      2014 Annual Research Report
  • [Presentation] ABCトランスポーターからみた子宮体部漿液性腺癌の薬剤獲得耐性メカニズム2014

    • Author(s)
      鈴木史彦、永瀬智、佐藤いずみ、宇都宮裕貴、海法道子、徳永英樹、伊藤潔、新倉仁、高野忠夫、渡部洋、笹野公伸、八重樫伸生
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京)
    • Year and Date
      2014-04-18 – 2014-04-20
    • Related Report
      2014 Annual Research Report
  • [Presentation] 子宮体部漿液性腺癌薬剤耐性株におけるマイクロRNAの網羅的発現解析およびmiR-200 familyの発現解析2014

    • Author(s)
      佐藤いずみ、永瀬智、鈴木史彦、永井智之、田中創大、海法道子、徳永英樹、高野忠夫、新倉仁、伊藤潔、渡部洋、八重樫伸生
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京)
    • Year and Date
      2014-04-18 – 2014-04-20
    • Related Report
      2014 Annual Research Report
  • [Presentation] 子宮体部漿液性腺癌に対するmiR-101を用いた分子標的治療の可能性

    • Author(s)
      鈴木史彦、永瀬智、佐藤いずみ、宇都宮裕貴、新倉 仁、渡部洋、笹野公伸、八重樫伸生
    • Organizer
      第13回日本婦人科がん分子標的研究会
    • Place of Presentation
      鳥取
    • Related Report
      2013 Research-status Report
  • [Presentation] 子宮体部漿液性腺癌におけるマイクロRNAの発現異常

    • Author(s)
      永瀬智
    • Organizer
      熊本大学産婦人科セミナー
    • Place of Presentation
      熊本
    • Related Report
      2012 Research-status Report
    • Invited

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi